Moleculin Biotech, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold MBRX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
5
Funds holding
$67022
Total value held
Buying
4 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $55901 | 20036 | +20000 | +55555.56% |
| 2 | Citigroup Inc | $7460 | 2674 | +2674 | NEW BUY |
| 3 | Barclays Plc | $1733 | 621 | +621 | NEW BUY |
| 4 | Blackrock, Inc. | $1370 | 491 | — | Held |
| 5 | Wells Fargo & Company/Mn | $558 | 200 | +200 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.